Tango Therapeutics CEO Barbara Weber Retires, Malte Peters Takes Over
Tango Therapeutics announced the retirement of its Chief Executive Officer, Dr. Barbara Weber, effective January 8, 2026. Dr. Weber, the company's founding CEO, will become Executive Chair for 2026 and then serve as non-executive chair starting in 2027. She is succeeded by Dr. Malte Peters. In her new capacity as Executive Chair, Weber will remain closely involved with the senior management team of Tango, supporting the company's strategic priorities and working with Dr. Peters to ensure a seamless transition and continued clinical execution throughout 2026. Alexis Borisy, the current Board Chair, will transition to Lead Independent Director.
